|
Total 326 Docetaxel
Patents
(Data from US
Patent & Trademark Office)
No. 1
- 100 / 101-200
/ 201 - 300 / 301
- 326 /
No. 1 - 100 Docetaxel Patents:
|
PAT. NO. |
|
Title |
| 1 |
6,515,017 |
 |
Water
soluble paclitaxel derivatives |
| 2 |
6,515,016 |
|
Composition
and methods of paclitaxel for treating psoriasis |
| 3 |
6,515,004 |
|
N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide
inhibitors of cyclin dependent kinases |
| 4 |
6,514,983 |
|
Compounds,
methods and pharmaceutical compositions for treating neural or
cardiovascular tissue damage |
| 5 |
6,506,905 |
|
Method
of preparation of paclitaxel (taxol) using 3-(alk-2-ynyloxy)
carbonyl-5-oxazolidine carboxylic acid |
| 6 |
6,506,799 |
|
Methods
of treating cardiovascular diseases, dyslipidemia,
dyslipoproteinemia, and hypertension with ether compounds |
| 7 |
6,506,798 |
|
4-Arylamino,
4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as
selective MEK inhibitors |
| 8 |
6,506,437 |
|
Methods
of coating an implantable device having depots formed in a surface
thereof |
| 9 |
6,506,405 |
|
Methods
and formulations of cremophor-free taxanes |
| 10 |
6,503,954 |
|
Biocompatible
carrier containing actinomycin D and a method of forming the same |
| 11 |
6,503,893 |
|
Method
of treating hyperproliferative diseases using active vitamin D
analogues |
| 12 |
6,503,556 |
|
Methods
of forming a coating for a prosthesis |
| 13 |
6,500,966 |
|
Process
for the preparation of taxanes from 10-deacetylbaccatin III |
| 14 |
6,500,858 |
|
Taxoid
anti-tumor agents and pharmaceutical compositions thereof |
| 15 |
6,500,853 |
|
Inhibitors
of phospholipase enzymes |
| 16 |
6,500,405 |
|
Use
of certain amides as probes for detection of antitubulin activity
and resistance monitoring |
| 17 |
6,498,188 |
|
Methods
of treatment for cancer or viral infections |
| 18 |
6,497,904 |
|
Treatment
of oncologic tumors with an injectable formulation of a golgi
apparatus disturbing agent |
| 19 |
6,495,705 |
|
Efficient
process for the production of 10-DAB III by selective
hydrazinolysis of various taxanes |
| 20 |
6,495,579 |
|
Method
for treating multiple sclerosis |
| 21 |
6,495,129 |
|
Methods
of inhibiting hematopoietic stem cells using human myeloid
progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3) |
| 22 |
6,494,862 |
|
Substance
delivery apparatus and a method of delivering a therapeutic
substance to an anatomical passageway |
| 23 |
6,489,314 |
|
Epothilone
derivatives and methods for making and using the same |
| 24 |
6,486,204 |
|
Treatment
or prevention of prostate cancer with a COX-2 selective inhibiting
drug |
| 25 |
6,486,146 |
|
Cancer
accelerants and phase synchronization methods |
| 26 |
6,485,737 |
|
Biodegradable
terephthalate polyester-poly (phosphonate) compositions, articles
and methods of using the same |
| 27 |
6,482,963 |
|
C9
hydrido, hydroxy and acyloxy taxane derivatives and pharmaceutical
compositions containing them |
| 28 |
6,482,860 |
|
Pentafluorobenzenesulfonamides
and analogs |
| 29 |
6,482,843 |
|
Compounds
and methods for use thereof in the treatment of cancer or viral
infections |
| 30 |
6,482,842 |
|
3-aminopyrazole
inhibitors of cyclin dependent kinases |
| 31 |
6,482,802 |
|
Use
of neomycin for treating angiogenesis-related diseases |
| 32 |
6,479,679 |
|
Two-step
conversion of protected taxane ester to paclitaxel |
| 33 |
6,479,526 |
|
Pharmaceutical
composition for inhibiting the growth of viruses and cancers |
| 34 |
6,479,500 |
|
Agents
for alleviating side effects |
| 35 |
6,479,499 |
|
2-phenyl-4-quinazolinone
compounds, 2-phenyl-4-alkoxy-quinazoline compounds and their
pharmaceutical compositions |
| 36 |
6,479,067 |
|
Methods
for treating ovarian cancer, poly (phosphoester) compositions, and
biodegradable articles for same |
| 37 |
6,476,242 |
|
2-aroyl-4-acyl
paclitaxel (Taxol) analogs |
| 38 |
6,476,203 |
|
Safe
pharmaceutical composition for treating and preventing infertility
and increasing immune function |
| 39 |
6,476,043 |
|
Use
of camptothecin derivatives, with reduced gastrointestinal
toxicity |
| 40 |
6,472,507 |
|
Carrier
based drug delivery system |
| 41 |
6,472,420 |
|
Method
for treating a patient with neoplasia by treatment with a
paclitaxel derivative |
| 42 |
6,469,186 |
|
Process
for mass production of GMP paclitaxel and related taxanes |
| 43 |
6,469,050 |
|
7-hexanoyltaxol
and methods for preparing the same |
| 44 |
6,469,022 |
|
Method,
compositions and kits for increasing the oral bioavailability of
pharmaceutical agents |
| 45 |
6,469,004 |
|
Benzoheterocycles
and their uses as MEK inhibitors |
| 46 |
6,462,208 |
|
C7
acyloxy and hydrido taxane derivatives and pharmaceutical
compositions containing them |
| 47 |
6,462,062 |
|
Compounds
and methods for use thereof in the treatment of cancer or viral
infections |
| 48 |
6,462,041 |
|
Gambogic
acid, analogs and derivatives as activators of caspases and
inducers of apoptosis |
| 49 |
6,462,017 |
|
Method
of reducing side effects of chemotherapy in cancer patients |
| 50 |
6,459,003 |
|
Ether
compounds |
| 51 |
6,458,976 |
 |
Taxoid
anti-tumor agents, pharmaceutical compositions, and treatment
methods |
| 52 |
6,458,835 |
|
Method
of inhibiting or treating chemotherapy-induced hair loss |
| 53 |
6,458,347 |
|
Drug
complex |
| 54 |
6,455,582 |
|
Sulohydroxamic
acids and sulohyroxamates and their use as MEK inhibitors |
| 55 |
6,455,559 |
|
Phenylacetamido-pyrazole
derivatives, process for their preparation and their use as
antitumor agents |
| 56 |
6,452,025 |
|
Three-step
conversion of protected taxane ester to paclitaxel |
| 57 |
6,451,373 |
|
Method
of forming a therapeutic coating onto a surface of an implantable
prosthesis |
| 58 |
6,448,417 |
|
Methods
and useful intermediates for paclitaxel synthesis from C-7, C-10
di-cbz 10-deacetylbaccatin III |
| 59 |
6,448,264 |
|
Use
of 5-thio-, sulfinyl- and sulfonylpyrazolo[3,4-b]-pyridines as
cyclin dependent kinase inhibitors |
| 60 |
6,448,054 |
|
Purposeful
movement of human migratory cells away from an agent source |
| 61 |
6,447,542 |
|
Implantable
members for receiving therapeutically useful compositions |
| 62 |
6,444,638 |
|
Combinations
of PKC inhibitors and therapeutic agents for treating cancers |
| 63 |
6,441,253 |
|
Method
for the synthesis of taxanes |
| 64 |
6,441,026 |
|
Antitumor
compositions containing taxane derivatives |
| 65 |
6,441,025 |
|
Water
soluble paclitaxel derivatives |
| 66 |
6,441,017 |
|
Inhibitors
of prenyl-protein transferase |
| 67 |
6,440,966 |
|
Benzenesulfonamide
derivatives and their use as MEK inhibitors |
| 68 |
6,436,931 |
|
Cytotoxic
agents comprising taxanes and their therapeutic use |
| 69 |
6,433,187 |
|
Certain
polycyclic compounds useful as tubulin-binding agents |
| 70 |
6,432,639 |
|
Isolated
CYP3A4 nucleic acid molecules and detection methods |
| 71 |
6,428,579 |
|
Implantable
prosthetic devices coated with bioactive molecules |
| 72 |
6,423,753 |
|
Use
of colchinol derivatives as vascular damaging agents |
| 73 |
6,423,740 |
|
Chalcones
having antiproliferative activity |
| 74 |
6,423,736 |
|
Compounds
and methods for use thereof in the treatment of cancer or viral
infections |
| 75 |
6,423,735 |
|
Compounds
and methods for use thereof in the treatment of cancer or viral
infections |
| 76 |
6,420,591 |
|
Carbamates
and compositions thereof, and methods for their use for treating
cancer, inflammation, or a viral infection |
| 77 |
6,420,411 |
|
Compounds
and methods for use thereof in the treatment of cancer or viral
infections |
| 78 |
6,420,378 |
|
Inhibition
of abnormal cell proliferation with camptothecin and combinations
including the same |
| 79 |
6,419,900 |
|
Formulation
and method for treating neoplasms by inhalation |
| 80 |
6,419,709 |
|
Biodegradable
terephthalate polyester-poly(Phosphite) compositions, articles, and
methods of using the same |
| 81 |
6,417,394 |
|
Specific
salt forms of triphenylethylene derivatives as selective estrogen
receptor modulators |
| 82 |
6,417,176 |
|
Arylsulfonanilide
phosphates |
| 83 |
6,413,964 |
|
Inhibitors
of prenyl-protein transferase |
| 84 |
6,413,957 |
|
Methods
of inhibiting cell proliferation using indeno [1,2-c]pyrazol-4-ones |
| 85 |
6,410,802 |
|
Methods
for synthesizing ether compounds and intermediates therefor |
| 86 |
6,410,757 |
|
Baccatin
derivatives and a process for producing the same |
| 87 |
6,410,756 |
|
Family
of Canadensol taxanes, the semi-synthetic preparation and
therapeutic use thereof |
| 88 |
6,410,534 |
|
Inhibitors
of prenyl-protein transferase |
| 89 |
6,409,750 |
|
Woven
bifurcated and trifurcated stents and methods for making the same |
| 90 |
6,407,244 |
|
Pyrrole-type
compounds, compositions, and methods for treating cancer or viral
diseases |
| 91 |
6,407,131 |
|
Compounds
and method for use thereof in the treatment of cancer or viral
infections |
| 92 |
6,407,124 |
|
Carbon
substituted aminothiazole inhibitors of cyclin dependent kinases |
| 93 |
6,407,105 |
|
Compounds
and methods for use thereof in the treatment of cancer or viral
infections |
| 94 |
6,407,103 |
|
Indeno
[1,2-c] pyrazol-4-ones and their uses |
| 95 |
6,403,758 |
|
Bioresorbable
compositions for implantable prostheses |
| 96 |
6,403,675 |
|
Biodegradable
compositions comprising poly(cycloaliphatic phosphoester) compounds,
articles, and methods for using the same |
| 97 |
6,395,770 |
|
Method
and compositions for administering taxanes orally to human patients |
| 98 |
6,395,749 |
|
Carboxamide
compounds, methods, and compositions for inhibiting PARP activity |
| 99 |
6,395,506 |
|
Device
for monitoring cells |
| 100 |
6,395,326 |
|
Apparatus
and method for depositing a coating onto a surface of a prosthesis |
No. 1
- 100 / 101-200
/ 201 - 300 / 301
- 326 /
|
